Selected research
Industry Research
BCG Tuberculosis (TB) Vaccine Industry Research Report 2026
Market perspective
The global BCG Tuberculosis (TB) Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for BCG Tuberculosis (TB) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for BCG Tuberculosis (TB) Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for BCG Tuberculosis (TB) Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of BCG Tuberculosis (TB) Vaccine include China National Biotec, Sanofi Pasteur, Merck, Serum Institute of India, Japan BCG Lab, Intervax and GSBPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global BCG Tuberculosis (TB) Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
BCG Tuberculosis (TB) Vaccine Market by Company
China National Biotec
Sanofi Pasteur
Merck
Serum Institute of India
Japan BCG Lab
Intervax
GSBPL
BCG Tuberculosis (TB) Vaccine Segment by Type
Immune BCG
Therapy BCG
BCG Tuberculosis (TB) Vaccine Segment by Application
Hospital
Clinic
BCG Tuberculosis (TB) Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global BCG Tuberculosis (TB) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of BCG Tuberculosis (TB) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of BCG Tuberculosis (TB) Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of BCG Tuberculosis (TB) Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of BCG Tuberculosis (TB) Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of BCG Tuberculosis (TB) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Immune BCG
- Therapy BCG
Applications
- Hospital
- Clinic
Companies covered
- China National Biotec
- Sanofi Pasteur
- Merck
- Serum Institute of India
- Japan BCG Lab
- Intervax
- GSBPL
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global BCG Tuberculosis (TB) Vaccine Market Size (2021-2032)
- 2.2.2 Global BCG Tuberculosis (TB) Vaccine Sales (2021-2032)
- 2.2.3 Global BCG Tuberculosis (TB) Vaccine Market Average Price (2021-2032)
- 2.3 BCG Tuberculosis (TB) Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Immune BCG
- 2.3.3 Therapy BCG
- 2.4 BCG Tuberculosis (TB) Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global BCG Tuberculosis (TB) Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global BCG Tuberculosis (TB) Vaccine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global BCG Tuberculosis (TB) Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global BCG Tuberculosis (TB) Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global BCG Tuberculosis (TB) Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of BCG Tuberculosis (TB) Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of BCG Tuberculosis (TB) Vaccine, Product Type & Application
- 3.8 Global Manufacturers of BCG Tuberculosis (TB) Vaccine, Established Date
- 3.9 Global BCG Tuberculosis (TB) Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 China National Biotec
- 4.1.1 China National Biotec Company Information
- 4.1.2 China National Biotec Business Overview
- 4.1.3 China National Biotec BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 China National Biotec BCG Tuberculosis (TB) Vaccine Product Portfolio
- 4.1.5 China National Biotec Recent Developments
- 4.2 Sanofi Pasteur
- 4.2.1 Sanofi Pasteur Company Information
- 4.2.2 Sanofi Pasteur Business Overview
- 4.2.3 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Pasteur BCG Tuberculosis (TB) Vaccine Product Portfolio
- 4.2.5 Sanofi Pasteur Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck BCG Tuberculosis (TB) Vaccine Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Serum Institute of India
- 4.4.1 Serum Institute of India Company Information
- 4.4.2 Serum Institute of India Business Overview
- 4.4.3 Serum Institute of India BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Serum Institute of India BCG Tuberculosis (TB) Vaccine Product Portfolio
- 4.4.5 Serum Institute of India Recent Developments
- 4.5 Japan BCG Lab
- 4.5.1 Japan BCG Lab Company Information
- 4.5.2 Japan BCG Lab Business Overview
- 4.5.3 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Japan BCG Lab BCG Tuberculosis (TB) Vaccine Product Portfolio
- 4.5.5 Japan BCG Lab Recent Developments
- 4.6 Intervax
- 4.6.1 Intervax Company Information
- 4.6.2 Intervax Business Overview
- 4.6.3 Intervax BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Intervax BCG Tuberculosis (TB) Vaccine Product Portfolio
- 4.6.5 Intervax Recent Developments
- 4.7 GSBPL
- 4.7.1 GSBPL Company Information
- 4.7.2 GSBPL Business Overview
- 4.7.3 GSBPL BCG Tuberculosis (TB) Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSBPL BCG Tuberculosis (TB) Vaccine Product Portfolio
- 4.7.5 GSBPL Recent Developments
5 Global BCG Tuberculosis (TB) Vaccine Market Scenario by Region
- 5.1 Global BCG Tuberculosis (TB) Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021-2032
- 5.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2021-2026
- 5.2.2 Global BCG Tuberculosis (TB) Vaccine Sales by Region: 2027-2032
- 5.3 Global BCG Tuberculosis (TB) Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global BCG Tuberculosis (TB) Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Region: 2027-2032
- 5.4 North America BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
- 5.4.1 North America BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
- 5.4.3 North America BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
- 5.5.1 Europe BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
- 5.7.1 South America BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
- 5.7.3 South America BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa BCG Tuberculosis (TB) Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa BCG Tuberculosis (TB) Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa BCG Tuberculosis (TB) Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032)
- 6.1.1 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global BCG Tuberculosis (TB) Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032)
- 7.1.1 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global BCG Tuberculosis (TB) Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global BCG Tuberculosis (TB) Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global BCG Tuberculosis (TB) Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global BCG Tuberculosis (TB) Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global BCG Tuberculosis (TB) Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 BCG Tuberculosis (TB) Vaccine Value Chain Analysis
- 8.1.1 BCG Tuberculosis (TB) Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 BCG Tuberculosis (TB) Vaccine Production Mode & Process
- 8.2 BCG Tuberculosis (TB) Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 BCG Tuberculosis (TB) Vaccine Distributors
- 8.2.3 BCG Tuberculosis (TB) Vaccine Customers
9 Global BCG Tuberculosis (TB) Vaccine Analyzing Market Dynamics
- 9.1 BCG Tuberculosis (TB) Vaccine Industry Trends
- 9.2 BCG Tuberculosis (TB) Vaccine Industry Drivers
- 9.3 BCG Tuberculosis (TB) Vaccine Industry Opportunities and Challenges
- 9.4 BCG Tuberculosis (TB) Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst